Quest Partners LLC Purchases New Stake in Danaher Co. (NYSE:DHR)

Quest Partners LLC bought a new position in shares of Danaher Co. (NYSE:DHR - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,981 shares of the conglomerate's stock, valued at approximately $1,941,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. nVerses Capital LLC bought a new position in shares of Danaher during the second quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher in the second quarter valued at $25,000. MFA Wealth Advisors LLC bought a new stake in Danaher in the 2nd quarter valued at about $51,000. Financial Connections Group Inc. bought a new stake in shares of Danaher during the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher in the 1st quarter worth approximately $55,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. KeyCorp raised their target price on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research note on Wednesday, October 23rd. The Goldman Sachs Group raised their price objective on Danaher from $225.00 to $250.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 24th. TD Cowen boosted their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. UBS Group cut their price objective on Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Finally, Robert W. Baird decreased their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $287.16.

Danaher Stock Performance

Shares of DHR stock traded up $0.78 during mid-day trading on Tuesday, reaching $230.84. The stock had a trading volume of 2,483,207 shares, compared to its average volume of 2,764,104. The firm has a market cap of $166.73 billion, a PE ratio of 44.13, a P/E/G ratio of 4.24 and a beta of 0.85. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a one year low of $207.63 and a one year high of $281.70. The firm's 50 day simple moving average is $261.33 and its 200 day simple moving average is $260.45.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business's revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.02 earnings per share. On average, analysts forecast that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date was Friday, September 27th. Danaher's payout ratio is 20.61%.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company's stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 10.90% of the stock is currently owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.